Pharming Group N.V. announced the appointment of Anurag Relan as Chief Medical Officer (CMO), effective immediately, and Robert Friesen as Chief Scientific Officer, effective from 1 August 2021. Anurag and Robert will be the successors of Bruno Giannetti, who was Chief Operating Officer and Chief Medical Officer from 2019. Bruno announced his retirement from the Executive Committee at Pharming's recent Annual General Meeting of Shareholders, Bruno will stay with the company on a consultancy basis. Anurag Relan is currently Vice President, Clinical Research and Medical Affairs at Pharming, having held a number of roles within the Company during the past 15 years. Robert Friesen brings more than 20 years of experience in drug discovery and development across a number of listed biotech companies. Robert is currently CSO of Kiadis Pharma, which was acquired by Sanofi in April 2021, and was previously CSO of Ablynx, which was acquired by Sanofi in June 2018.